Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

712
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
712
Conjugated Proteins02:50

Conjugated Proteins

18.4K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

835
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
835
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

15.5K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.5K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

5.8K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.8K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

237
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
237

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives.

Molecules (Basel, Switzerland)·2021
Same author

Patterns of calcium signaling: A link between chronic emotions and cancer.

Journal of integrative neuroscience·2017
Same author

Immobilization of Neutral Protease from Bacillus subtilis for Regioselective Hydrolysis of Acetylated Nucleosides: Application to Capecitabine Synthesis.

Molecules (Basel, Switzerland)·2016
Same author

Electromagnetic homeostasis and the role of low-amplitude electromagnetic fields on life organization.

Electromagnetic biology and medicine·2016
Same author

Electromagnetic effects in medicinal chemistry.

Current topics in medicinal chemistry·2015
Same author

Quantum neurophysics: From non-living matter to quantum neurobiology and psychopathology.

International journal of psychophysiology : official journal of the International Organization of Psychophysiology·2015
Same journal

Quantum annealing for enhanced feature selection in single-cell RNA sequencing data analysis.

Quantum machine intelligence·2026
Same journal

Hybrid Quantum-Classical Algorithm for Robust Optimization via Stochastic-Gradient Online Learning.

Quantum machine intelligence·2026
Same journal

Benchmarking the operation of quantum heuristics and Ising machines: scoring parameter setting strategies on optimization applications.

Quantum machine intelligence·2025
Same journal

Unsupervised beyond-standard-model event discovery at the LHC with a novel quantum autoencoder.

Quantum machine intelligence·2025
Same journal

Quantum transfer learning for breast cancer detection.

Quantum machine intelligence·2022
Same journal

Quantum-accessible reinforcement learning beyond strictly epochal environments.

Quantum machine intelligence·2021
See all related articles

Related Experiment Video

Updated: Aug 11, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.4K

SARS-CoV-2 spike and ACE2 entanglement-like binding.

Massimo Pregnolato1, Paola Zizzi2

  • 1Department of Drug Science, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.

Quantum Machine Intelligence
|February 6, 2023
PubMed
Summary
This summary is machine-generated.

This article proposes a novel theoretical framework describing how the SARS-CoV-2 Spike protein binds to human ACE2 receptors using concepts from quantum computing. The authors model the interaction as a quantum circuit involving superposition and entanglement gates. They further suggest two potential therapeutic strategies: using inhibitors that outcompete the receptor for binding or using covalent agents to disrupt the protein structure. Finally, the authors hypothesize that the Spike protein subunit might function like a quantum bio-robot.

Keywords:
ACE2EntanglementQuantum robotsQubitSpike proteinviral entryprotein bindingbiophysicscomputational modeling

Frequently Asked Questions

More Related Videos

High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
06:39

High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells

Published on: April 21, 2022

3.1K
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

59.1K

Related Experiment Videos

Last Updated: Aug 11, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.4K
High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
06:39

High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells

Published on: April 21, 2022

3.1K
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

59.1K

Area of Science:

  • Computational biophysics and SARS-CoV-2 protein interaction research
  • Quantum information science applied to molecular biology

Background:

No prior work had resolved the precise computational dynamics of viral protein attachment through quantum logic frameworks. That uncertainty drove researchers to explore non-traditional models for understanding molecular binding events. It was already known that viral glycoproteins facilitate host cell entry by interacting with specific surface receptors. Prior research has shown that these interactions are typically analyzed through classical thermodynamic or kinetic perspectives. This gap motivated a shift toward applying quantum circuit theory to biological systems. No prior work had established a direct mapping between protein subunits and quantum logic gates. That uncertainty drove the need for a new theoretical lens to interpret complex molecular recognition. This study addresses the lack of quantum-mechanical descriptions for viral entry mechanisms.

Purpose Of The Study:

The aim of this study is to describe the binding interaction between the SARS-CoV-2 Spike glycoprotein and the human ACE2 receptor as a quantum circuit. This research addresses the need for novel theoretical frameworks to explain viral entry mechanisms at a molecular level. The authors seek to map biological protein interactions onto established quantum logic gate operations. This motivation stems from the complexity of viral binding that classical models may not fully capture. The study investigates how superposition and entanglement can represent the physical association of these proteins. It also explores potential strategies to inhibit this binding process using quantum-inspired therapeutic approaches. The researchers define the specific roles of competitive and covalent inhibitors within this computational architecture. This work provides a foundation for viewing viral components through the lens of quantum information science.

Main Methods:

The review approach involved constructing a theoretical model based on quantum information theory principles. Researchers mapped the biological binding process onto a standard quantum circuit architecture. They utilized the Hadamard gate to represent the superposition state of the viral protein subunit. The team employed the CNOT gate to simulate the entanglement between the Spike protein and the host receptor. This investigative strategy focused on identifying logical parallels between molecular interactions and computational gates. The authors evaluated two distinct inhibitory strategies using this mathematical framework. They compared the efficacy of competitive binding agents against covalent disruption methods. This analytical design allowed for the formulation of a novel hypothesis regarding the functional nature of the viral subunit.

Main Results:

The strongest finding indicates that the viral binding process can be modeled as a quantum circuit with specific logic gates. The S1 subunit undergoes superposition through a one-qubit Hadamard gate. Maximum entanglement between S1 and the ACE2 receptor is achieved via a two-qubit CNOT gate. Competitive peptidomimetic inhibitors are identified as agents that bind to the receptor binding domain with higher affinity than the natural receptor. These inhibitors successfully target the CNOT gate to replace the host protein. Covalent inhibitors are shown to function as a projective quantum measurement. This measurement process leads to the destruction of the S1 subunit. The authors conclude by formulating the conjecture that the S1 subunit operates as a quantum bio-robot.

Conclusions:

The authors propose that the interaction between viral proteins and host receptors functions as a quantum circuit. This synthesis suggests that the Spike protein subunit acts as a quantum logic gate during binding. The researchers argue that competitive inhibitors might disrupt this process by replacing the natural receptor. Their analysis implies that these agents could achieve maximum entanglement with the viral subunit. The study further posits that covalent inhibitors could act as projective measurements to destroy the protein. This review of the literature suggests that the Spike subunit might operate as a quantum bio-robot. The authors conclude that these quantum-based strategies offer new pathways for therapeutic intervention. These implications highlight the potential for applying quantum information theory to viral pathogenesis.

The researchers propose that the binding process functions as a quantum circuit. This mechanism utilizes a one-qubit Hadamard gate for superposition of the S1 subunit and a two-qubit CNOT gate to facilitate maximum entanglement between the viral protein and the human ACE2 receptor.

The authors introduce the concept of the S1 subunit as a quantum bio-robot. This theoretical construct suggests that the protein component may exhibit autonomous, programmable-like behavior within the quantum circuit framework during the viral entry process.

A CNOT gate is necessary to perform the maximum entanglement between the Spike-qubit S1 and the ACE2 receptor protein. This specific logic gate is required to model the transition from superposition to a bound state within the proposed circuit.

Competitive peptidomimetic inhibitors act as a data-disrupting component. These agents are designed to target the CNOT gate, becoming entangled with the S1 qubit instead of the natural receptor, thereby preventing the viral protein from successfully binding to the host cell.

The researchers measure the effectiveness of covalent inhibitors by their ability to act as a projective quantum measurement. This phenomenon results in the destruction of the S1 subunit, effectively terminating the quantum circuit and preventing the viral binding process.

The authors imply that these quantum-based strategies offer new pathways for therapeutic intervention. By targeting the specific logic gates of the binding circuit, researchers may develop more effective methods to block viral entry compared to traditional pharmacological approaches.